Recent advances in lymphatic targeted drug delivery system for tumor metastasis

Area of Science:

• Oncology
• Pharmacology
• Biomedical Engineering

Background:

• The lymphatic system plays a crucial defensive role, but it's also a primary pathway for tumor metastasis.
• Lymphatic metastatic tumors develop rapidly and pose significant treatment challenges due to limitations in current therapies.
• Lymph node metastasis is a critical indicator of tumor spread and patient prognosis.

Purpose of the Study:

• To review the principles underlying lymphatic targeted drug delivery.
• To discuss recent advancements in lymphatic targeted drug delivery carriers.
• To highlight novel strategies for improving anticancer drug specificity in lymph nodes.

Main Methods:

• Literature review of existing research on lymphatic drug delivery.
• Analysis of principles governing lymphatic targeting mechanisms.
• Synthesis of recent developments in lymphatic targeted carrier technologies.

Main Results:

• Established principles of lymphatic drug delivery are summarized.
• Recent innovations in lymphatic targeted carriers are detailed.
• The potential of these systems to enhance drug specificity is discussed.

Conclusions:

• Lymphatic targeted drug delivery systems offer a promising approach to overcome challenges in treating lymphatic metastatic tumors.
• Further development of these targeted carriers is crucial for improving therapeutic outcomes.
• These systems enhance the specificity of anticancer drugs, targeting tumor cells within lymph nodes effectively.